{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:50:54Z","timestamp":1791435054873,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001453"],"award-info":[{"award-number":["UL1TR001453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"National Cancer Institute Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011353","name":"University of Massachusetts Chan Medical School Center for Clinical and Translational Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.celrep.2025.115709","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:57:02Z","timestamp":1747151822000},"page":"115709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-6500","authenticated-orcid":false,"given":"Krishna Kumar","family":"Ganta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonyeong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Carrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Chandramouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Luzuriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.115709_bib1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115709_bib2","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2025.115709_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115709_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","article-title":"Multiple sclerosis after infectious mononucleosis","volume":"64","author":"Nielsen","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.celrep.2025.115709_bib5","article-title":"The Epstein-Barr Virus EBNA1 Protein","volume":"2012","author":"Frappier","year":"2012","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.celrep.2025.115709_bib6","series-title":"Epstein Barr Virus Volume 2: One Herpes Virus: Many Diseases","first-page":"3","article-title":"EBNA1","author":"Frappier","year":"2015"},{"key":"10.1016\/j.celrep.2025.115709_bib7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fneur.2019.01368","article-title":"High Levels of Epstein-Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk","volume":"10","author":"Hedstrom","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.celrep.2025.115709_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/gene.2011.42","article-title":"Epstein-Barr virus and multiple sclerosis: interaction with HLA","volume":"13","author":"Sundqvist","year":"2012","journal-title":"Genes Immun."},{"key":"10.1016\/j.celrep.2025.115709_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg3032","article-title":"Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis","volume":"9","author":"Thomas","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.115709_bib10","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1073\/pnas.1902623116","article-title":"Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk","volume":"116","author":"Tengvall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.115709_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115709_bib12","doi-asserted-by":"crossref","first-page":"e01562-16","DOI":"10.1128\/JVI.01562-16","article-title":"High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis","volume":"91","author":"Weiss","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.115709_bib13","doi-asserted-by":"crossref","first-page":"e01466-17","DOI":"10.1128\/JVI.01466-17","article-title":"Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection","volume":"92","author":"Weiss","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.115709_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/infdis\/130.3.231","article-title":"Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis","volume":"130","author":"Henie","year":"1974","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2025.115709_bib15","article-title":"Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern","volume":"14","author":"McNamara","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2025.115709_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"International Multiple Sclerosis Genetics Consortium","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115709_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jneuroim.2009.08.004","article-title":"Antibodies to specific EBNA-1 domains and HLA DRB1\u22171501 interact as risk factors for multiple sclerosis","volume":"215","author":"Sundstrom","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.celrep.2025.115709_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.celrep.2025.115709_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.115709_bib20","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1038\/s41467-023-39189-8","article-title":"Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination","volume":"14","author":"Tong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115709_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jmv.10385","article-title":"Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1","volume":"70","author":"McClain","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.celrep.2025.115709_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41590-022-01156-8","article-title":"Molecular mimicry in MS","volume":"23","author":"Dempsey","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.115709_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/infdis\/jiad116","article-title":"Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections","volume":"228","author":"Singh","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2025.115709_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2215677","article-title":"SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines","volume":"19","author":"Hickey","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.celrep.2025.115709_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s44298-024-00063-z","article-title":"Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants","volume":"2","author":"Piepenbrink","year":"2024","journal-title":"Npj Viruses"},{"key":"10.1016\/j.celrep.2025.115709_bib26","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200212","article-title":"Complement Activation Is Associated With Disease Severity in Multiple Sclerosis","volume":"11","author":"Oechtering","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.celrep.2025.115709_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/13524585241237707","article-title":"Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023","volume":"30","author":"Goldacre","year":"2024","journal-title":"Mult. Scler."},{"key":"10.1016\/j.celrep.2025.115709_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.937583","article-title":"Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany","volume":"13","author":"Loosen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.115709_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11481-020-09948-1","article-title":"Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands","volume":"16","author":"Wang","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.celrep.2025.115709_bib30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","article-title":"Integrating risk factors: HLA-DRB1\u22171501 and Epstein-Barr virus in multiple sclerosis","volume":"70","author":"De Jager","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.115709_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0198-8859(93)90002-I","article-title":"MHC class II haplotypes and linkage disequilibrium in primates","volume":"36","author":"Gyllensten","year":"1993","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.celrep.2025.115709_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.13387","article-title":"The function of antibodies","volume":"328","author":"Daeron","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2025.115709_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4049\/jimmunol.2200956","article-title":"Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination","volume":"212","author":"Tong","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115709_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.21524","article-title":"Immunoglobulins and complement in postmortem multiple sclerosis tissue","volume":"65","author":"Barnett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.115709_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","article-title":"EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis","volume":"162","author":"van Sechel","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115709_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/2051-5960-2-53","article-title":"Complement activation in multiple sclerosis plaques: an immunohistochemical analysis","volume":"2","author":"Ingram","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.115709_bib37","doi-asserted-by":"crossref","first-page":"28232","DOI":"10.1073\/pnas.2013554117","article-title":"HLA tapasin independence: broader peptide repertoire and HIV control","volume":"117","author":"Bashirova","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.115709_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2025.115709_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2025.115709_bib40","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3389\/fimmu.2019.01851","article-title":"A Sample-Sparing Multiplexed ADCP Assay","volume":"10","author":"Butler","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.115709_bib41","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725004802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725004802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:16:24Z","timestamp":1776834984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725004802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2211124725004802"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115709","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.18.629009","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115709"}}